Rosen Law Firm Investigates Simulations Plus Securities Claims
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4d ago
0mins
Should l Buy SLP?
Source: PRnewswire
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for allegedly issuing misleading business information, highlighting serious concerns regarding the company's transparency.
- Significant Stock Decline: On July 15, 2025, Simulations Plus's stock plummeted by 25.75% following its third-quarter earnings report that fell short of expectations, indicating a lack of market confidence in the company's future performance, which could further erode investor trust.
- Poor Financial Performance: Although Simulations Plus reported sales of $20.4 million, a 10% year-over-year increase, it missed the consensus estimate of $20.9 million, reflecting the pressures and challenges the company faces in a competitive market.
- Class Action Opportunity: Investors can join the class action through the Rosen Law Firm without upfront costs, providing legal support for affected investors and potentially influencing future investment decisions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SLP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SLP
Wall Street analysts forecast SLP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLP is 19.00 USD with a low forecast of 19.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 14.140
Low
19.00
Averages
19.00
High
19.00
Current: 14.140
Low
19.00
Averages
19.00
High
19.00
About SLP
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for allegedly issuing materially misleading business information, indicating significant transparency issues within the company.
- Stock Price Plunge: On July 15, 2025, Simulations Plus' stock plummeted by 25.75% following the release of its third-quarter earnings report, reflecting a substantial decline in market confidence regarding the company's future performance, which could damage investor trust.
- Poor Financial Performance: Simulations Plus reported sales of $20.4 million, a 10% year-over-year increase, yet it fell short of the consensus estimate of $20.9 million, highlighting ongoing weakness in market demand that may affect future investment appeal.
- Class Action Preparation: Rosen Law Firm is preparing a class action for affected investors, promising compensation without upfront costs, indicating that the company faces legal risks that could further impact shareholder value.
See More

- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ: SLP) due to allegations of misleading business information, highlighting serious concerns about the company's transparency and accountability to investors.
- Performance Misses Expectations: Simulations Plus reported third-quarter sales of $20.4 million in 2025, a 10% year-over-year increase, but fell short of the consensus estimate of $20.9 million, indicating persistent demand weakness and declining market confidence.
- Significant Stock Drop: Following the disappointing earnings report on July 15, 2025, Simulations Plus's stock plummeted by 25.75%, resulting in substantial financial losses for investors and exacerbating concerns about the company's future performance.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit against Simulations Plus, allowing investors to participate in claims without upfront costs, demonstrating the firm's strong commitment to protecting investor rights and seeking recovery for losses.
See More
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for allegedly issuing misleading business information, highlighting serious concerns regarding the company's transparency.
- Significant Stock Decline: On July 15, 2025, Simulations Plus's stock plummeted by 25.75% following its third-quarter earnings report that fell short of expectations, indicating a lack of market confidence in the company's future performance, which could further erode investor trust.
- Poor Financial Performance: Although Simulations Plus reported sales of $20.4 million, a 10% year-over-year increase, it missed the consensus estimate of $20.9 million, reflecting the pressures and challenges the company faces in a competitive market.
- Class Action Opportunity: Investors can join the class action through the Rosen Law Firm without upfront costs, providing legal support for affected investors and potentially influencing future investment decisions.
See More

- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ: SLP) for possibly issuing misleading business information, indicating significant transparency issues within the company.
- Performance Misses Expectations: Simulations Plus reported third-quarter sales of $20.4 million in 2025, a 10% year-over-year increase, yet fell short of the consensus estimate of $20.9 million, highlighting weak demand and declining market confidence.
- Stock Price Plummets: Following the disappointing earnings report on July 15, 2025, Simulations Plus's stock dropped by 25.75%, which not only undermines investor confidence but may also lead to subsequent legal actions and compensation claims.
- Class Action Preparation: Rosen Law Firm is preparing a class action for affected investors, promising to assist in seeking compensation without upfront fees, demonstrating the firm's commitment to protecting investor rights and its professional capabilities.
See More

- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ: SLP) for allegedly issuing misleading business information, highlighting a commitment to protecting investor rights.
- Significant Stock Drop: On July 15, 2025, Simulations Plus's stock plummeted by 25.75% following the release of its third-quarter earnings report, indicating market concerns about the company's future outlook and potentially eroding investor confidence.
- Poor Financial Performance: Simulations Plus reported third-quarter sales of $20.4 million, a 10% year-over-year increase, yet this fell short of the consensus estimate of $20.9 million, reflecting ongoing weakness in demand that adversely affects its market performance.
- Legal Action Preparation: The Rosen Law Firm is preparing a class action to recover losses for investors, emphasizing the importance of selecting qualified legal counsel with a proven track record to ensure effective protection of investor interests.
See More

- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for possibly issuing misleading business information, allowing affected shareholders to seek compensation without any out-of-pocket costs.
- Performance Miss: Simulations Plus reported $20.4 million in sales for Q3 2025, a 10% year-over-year increase, but fell short of the $20.9 million consensus estimate, resulting in a 25.75% stock drop on July 15, 2025, indicating market concerns about the company's outlook.
- Class Action Preparation: The firm is preparing a class action lawsuit against Simulations Plus to recover investor losses, emphasizing the importance of selecting qualified legal counsel with a proven track record in securities litigation to protect investor rights effectively.
- Firm's Strength: Rosen Law Firm secured over $438 million for investors in 2019 and achieved the largest securities class action settlement against a Chinese company in 2017, showcasing its significant expertise and success in the securities litigation field.
See More







